c-K-ras overexpression is characteristic for metastases derived from a methylcholanthrene-induced fibrosarcoma

Invasion and Metastasis

Volumn 18, Issue 5-6, 1998, Pages 261-270

  Algarra, Ignacio ^a   Perez, Matias ^b   Serrano, M José ^a   Garrido, Federico ^b   Gaforio, José Juan ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

c K ras; c myc; Chemical carcinogenesis; Metastatic phenotype; Neoplastic transformation; NK cells

Indexed keywords

3 METHYLCHOLANTHRENE; MESSENGER RNA; MYC PROTEIN; RAS PROTEIN;

ANIMAL CELL; ANIMAL DISEASE; ANIMAL MODEL; ARTICLE; CHEMICAL CARCINOGENESIS; FIBROSARCOMA; GENE ACTIVATION; GENE OVEREXPRESSION; KIDNEY; LIVER; LUNG; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PROTO ONCOGENE; TUMOR CELL CULTURE;

EID: 0032466370     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024519     Document Type: Article

References (41)

1. Weinberg RA: Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989;49:3713-3721.
2. Lenardo M, Rustgi AK, Schievella AR, Bernards R: Suppression of MHC class I gene expression by N-myc through enhancer inactivation. EMBO J 1989;8:3351-3358.
3. Versteeg R, Noordermeer IA, Kruse-Walters M, Ruiter D, Schrier PJ: c-myc down-regulates class I HLA expression in human melanomas. EMBO J 1988;7:1023-1029.
4. Ruiz-Cabello F, Klein E, Garrido F: MHC antigens on human tumors. Immunol Lett 1991;29:181-190.
5. Barbacid M: ras genes. Annu Rev Biochem 1987;56:779-827.
6. Sukumar S: ras oncogenes in chemical carcinogenesis. Curr Top Microbiol Immunol 1989;148:83-114.
7. Bourne HR, Sanders DA, McCormick F: The GTPase superfamily: A conserved switch for diverse cell functions. Nature 1990;348:125-132.
8. Lu YY, Blair DG, Segal S, Shih TY, Clanton DJ: Tumorigenicity, metastasis and suppression of MHC class I expression in murine cells transformed by mutant v-ras deficient in GTP binding. Int J Cancer Suppl 1991;6:45-48.
9. Land H, Parada LF, Weinberg RA: Tumorigenic conversion of primary embryo fibroblast requires at least two coooperating oncogenes. Nature 1983;304:596-602.
10. Fearon ER: Genetic alterations underlying colorectal tumorigenesis. Cancer Surv 1991;12:119-136.
11. Pérez M, Garrido A, Algarra I, Garrido F: Different H-2 in clones derived from a new BALB/c solid tumor. Its relevance for tumor growth. Immunología 1985;4:60-69.
12. Garrido A, Pérez M, Delgado C, Garrido ML, Rojano J, Algarra I, Garrido F: Influence of class 1 H-2 gene expression on local tumor growth. Description of a model obtained from clones derived from a solid BALB/c tumor. Exp Clin Immunogenet 1986;13:98-110.
13. Pérez M, Algarra I, Ljunggren HG, Caballero A, Mialdea MJ, Gaforio JJ, Klein G, Karre K, Garrido F: A weakly tumorigenic phenotype with high MHC class I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma. Int J Cancer 1990;46:258-261.
14. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-5299.
15. Blin N, Stafford DW: A general method for isolation of high molecular weight DNA from eukarotes. Nucleic Acids Res 1976;3:2303-2308.
16. Dalla-Favera R, Gelmann EP, Martinotti S, Franchini G, Papas TS, Gallo RC, Wong-Staal F: Cloning and characterization of different human sequences related to the one gene (v-myc) of avian myelocytomatosis virus (MC29). Proc Nat Acad Sci USA 1982;79:6497-6501.
17. Ellis RW, Defeo D, Shih TY, Gonda MA, Young HA, Tsuchida N, Lowy DR, Scolnick EM: The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature 1981;292:506-511.
18. Nudel U, Zakut R, Shani M, Neuman S, Levy A, Yaffe D: The nucleotide sequence of the rat cytoplasmic β-actin gene. Nucleic Acids Res 1981;11:1759-1771.
19. Janssen JWG, Lyons L, Steenvoorden AC, Seliger H, Bartra CR: Concurrent mutations in two different ras genes in acute myelocytic leukemias. Nucleic Acids Res 1987;15: 5669-5680.
20. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-491.
21. Oliva MR, Cabrera T, Esquivias J, Perez-Ayala M, Redondo M, Ruiz-Cabello F, Garrido F: K-ras mutations (codon 12) are not involved in down-regulation of MHC class-I genes in colon carcinomas. Int J Cancer 1990;146:426-431.
22. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA: Molecular aspects of tumor cell invasion and metastasis. Cancer 1993; 71:1368-1383.
23. Liu E, Hjelle B, Morgan R, Hecht F, Bishop JM: Mutations of the Kirsten-ras proto-oncogene in human preleukaemia. Nature 1987;300: 186-188.
24. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM: Amplification of N-myc in untreated human neuroblastoma correlated with advanced disease stage. Science 1984;244:1121-1124.
25. Niwa O, Kamiya K, Furihata C, Nitta Y, Wang Z, Fan YJ, Ninomiya Y, Kotomura N, Numoto M, Kominami R: Association of minisatellite instability with c-myc amplification and K-ras mutation in methylcholanthrene-induced mouse sarcomas. Cancer Res 1995;55:5670-5676.
26. Kozma L, Kiss I, Nagv A, Szakáll S, Ember I: Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma. Cancer Lett 1997;111:127-131.
27. Sekine I, Takami S, Guang SG, Yokose T, Kodama T, Nishiwaki Y, Kinoshita M, Matsumoto H, Ogura T, Nagai K: Role of epidermal growth factor receptor overexpression, K-ras point mutation and c-myc amplification in the carcinogenesis of non-small cell lung cancer. Oncol Rep 1998;5:351-354.
28. Kretzner L, Blackwood EM, Eisenman RN: Myc and Max proteins possess distinct transcriptional activities. Nature 1992;359:426-429.
29. Gaforio JJ, Pérez M, Algarra I, Mialdea MJ, Ljunggren HG, Garrido F: Differential mRNA levels of c-myc, c-fos and MHC class I in several clones of a murine fibrosarcoma. Int J Cancer 1991;49:906-910.
30. Algarra I, Öhlén C, Pérez M, Ljunggren HG, Klein G, Garrrido F, Karre K: NK sensitivity and lung clearance of MHC-class-I-deficient cells within a heterogeneous fibrosarcoma. Int J Cancer 1989;44:675-680.
31. Peltenburg LT, Steegenga WT, Krüse KM, Schrier PI. C-myc-induced natural killer cell sensitivity of human melanoma cells is reversed by HLA-B27 transfection. Eur J Immunol 1992;22:2737-2740.
32. Algarra I, Pérez M, Gaforio JJ, Gasca F, Garrido F: In vivo activation of NK cells induces inhibition of lung colonization of H-2 positive and H-2 negative fibrosarcoma tumor clones. Clin Exp Metastasis 1994;13:31-36.
33. Algarra I, Gonzalez A, Pérez M, Gaforio JJ, Garrido F: Effect of in vivo activation of natural killer (NK) cells by a tilorone analogue on the survival of mice injected intravenously with different experimental murine tumours. Clin Exp Immunol 1996;103:499-505.
34. Algarra I, Gaforio JJ, Garrido A, Mialdea MJ, Pérez M, Garrido F: Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis. Int J Cancer Suppl 1991;6:73-81.
35. Hanna N: Inhibition of experimental tumor metastasis by selective activation of natural killer cells. Cancer Res 1982;42:1337-1342.
36. Roth C, Rochlitz C, Kourilsky P: Immune response against tumors. Adv Immunol 1994;57:281-351.
37. Höglund P, Sundback J, Olsson-Alheim MY, Johansson M, Salcedo M, Öhlen C, Ljunggren HG, Sentman CL, Kärre K: Host MHC class I gene control of NK-cell specificity in the mouse. Immunol Rev 1997;155:11-28.
38. Pedrinaci S, Algarra I, Garcia Lora A, Gaforio JJ, Pérez M, Garrido F: Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma. Int J Clin Lab Res, in press.
39. Garrido F, Ruiz-Cabello F, Cabrera T, Pérez-Villar JJ, López-Botet M, Duggan-Keen M, Stern PL: Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today 1997;18:89-95.
40. Thorgeirsson UP, Turpeenniemi-Hujanaen T, Williams JE, Westin EH, Heilman CA, Talmadge JE, Liotta LA: NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol 1985;5: 259-262.
41. Greig RG, Koestler TP, Trainer DL, Corwin SP, Miles L, Kline T, Sweet R, Yokoyama S, Poste G: Tumorigenic and metastatic properties of 'normal' and ras-transfected NIH/ 3T3 cells. Proc Natl Acad Sci USA 1985;82:3698-3701.